343 related articles for article (PubMed ID: 30706776)
41. Graphene-based nanomaterials as molecular imaging agents.
Garg B; Sung CH; Ling YC
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):737-58. PubMed ID: 25857851
[TBL] [Abstract][Full Text] [Related]
42. Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy.
Yang K; Feng L; Liu Z
Adv Drug Deliv Rev; 2016 Oct; 105(Pt B):228-241. PubMed ID: 27233212
[TBL] [Abstract][Full Text] [Related]
43. Acoustic cavitation induced generation of stabilizer-free, extremely stable reduced graphene oxide nanodispersion for efficient delivery of paclitaxel in cancer cells.
Geetha Bai R; Muthoosamy K; Shipton FN; Manickam S
Ultrason Sonochem; 2017 May; 36():129-138. PubMed ID: 28069192
[TBL] [Abstract][Full Text] [Related]
44. Graphene: A Comprehensive Review.
Ghuge AD; Shirode AR; Kadam VJ
Curr Drug Targets; 2017; 18(6):724-733. PubMed ID: 27397067
[TBL] [Abstract][Full Text] [Related]
45. Graphene as multifunctional delivery platform in cancer therapy.
Nejabat M; Charbgoo F; Ramezani M
J Biomed Mater Res A; 2017 Aug; 105(8):2355-2367. PubMed ID: 28371194
[TBL] [Abstract][Full Text] [Related]
46. Preparation and tumor cell model based biobehavioral evaluation of the nanocarrier system using partially reduced graphene oxide functionalized by surfactant.
Wang Y; Liu K; Luo Z; Duan Y
Int J Nanomedicine; 2015; 10():4605-20. PubMed ID: 26229464
[TBL] [Abstract][Full Text] [Related]
47. Graphene oxide: a carrier for pharmaceuticals and a scaffold for cell interactions.
Durán N; Martinez DS; Silveira CP; Durán M; de Moraes AC; Simões MB; Alves OL; Fávaro WJ
Curr Top Med Chem; 2015; 15(4):309-27. PubMed ID: 25579346
[TBL] [Abstract][Full Text] [Related]
48. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
[TBL] [Abstract][Full Text] [Related]
49. Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells.
Tiwari H; Karki N; Pal M; Basak S; Verma RK; Bal R; Kandpal ND; Bisht G; Sahoo NG
Colloids Surf B Biointerfaces; 2019 Jun; 178():452-459. PubMed ID: 30921680
[TBL] [Abstract][Full Text] [Related]
50. Recent progress of functionalised graphene oxide in cancer therapy.
Yi L; Zhang Y; Shi X; Du X; Wang X; Yu A; Zhai G
J Drug Target; 2019 Feb; 27(2):125-144. PubMed ID: 29730956
[TBL] [Abstract][Full Text] [Related]
51. Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?
Hoseini-Ghahfarokhi M; Mirkiani S; Mozaffari N; Abdolahi Sadatlu MA; Ghasemi A; Abbaspour S; Akbarian M; Farjadian F; Karimi M
Int J Nanomedicine; 2020; 15():9469-9496. PubMed ID: 33281443
[TBL] [Abstract][Full Text] [Related]
52. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier.
Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399
[TBL] [Abstract][Full Text] [Related]
53. Carbon Nanomaterials in Biological Studies and Biomedicine.
Teradal NL; Jelinek R
Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28777502
[TBL] [Abstract][Full Text] [Related]
54. Ag and Au nanoparticles/reduced graphene oxide composite materials: Synthesis and application in diagnostics and therapeutics.
Darabdhara G; Das MR; Singh SP; Rengan AK; Szunerits S; Boukherroub R
Adv Colloid Interface Sci; 2019 Sep; 271():101991. PubMed ID: 31376639
[TBL] [Abstract][Full Text] [Related]
55. Natural and synthetic polymer for graphene oxide mediated anticancer drug delivery-A comparative study.
Deb A; R V
Int J Biol Macromol; 2018 Feb; 107(Pt B):2320-2333. PubMed ID: 29055699
[TBL] [Abstract][Full Text] [Related]
56. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
Javanbakht S; Pooresmaeil M; Namazi H
Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
[TBL] [Abstract][Full Text] [Related]
57. Functionalized Graphene Oxide with Hepatocyte Targeting as Anti-Tumor Drug and Gene Intracellular Transporters.
Cao X; Zheng S; Zhang S; Wang Y; Yang X; Duan H; Huang Y; Chen Y
J Nanosci Nanotechnol; 2015 Mar; 15(3):2052-9. PubMed ID: 26413620
[TBL] [Abstract][Full Text] [Related]
58. Development of graphene based nanocomposites towards medical and biological applications.
Mousavi SM; Low FW; Hashemi SA; Lai CW; Ghasemi Y; Soroshnia S; Savardashtaki A; Babapoor A; Pynadathu Rumjit N; Goh SM; Amin N; Tiong SK
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1189-1205. PubMed ID: 32930615
[TBL] [Abstract][Full Text] [Related]
59. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
60. Hyperbranched polyglycerol-modified graphene oxide as an efficient drug carrier with good biocompatibility.
Mu S; Li G; Liang Y; Wu T; Ma D
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():639-646. PubMed ID: 28576032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
